As of 2:11pm ET
| +0.30 / +1.96%|
The 4 analysts offering 12-month price forecasts for Meridian Bioscience Inc have a median target of 14.00, with a high estimate of 15.00 and a low estimate of 9.00. The median estimate represents a -10.26% decrease from the last price of 15.60.
The current consensus among 7 polled investment analysts is to Hold stock in Meridian Bioscience Inc. This rating has held steady since October, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.